Ryan Lewis, Chief Business Developer of Global Cannabinoids, talks about the emerging markets for CBD and hemp-derived products.

Global Cannabinoids is a high volume producer and distributor of bulk and wholesale phytocannabinoid-rich (PCR) industrial hemp—naturally high in CBD, CBG, CBC, CBN, CBDA, and terpenes. Additionally, Global Cannabinoids is a large manufacturer of private- label CBD products, one of the biggest in the US. They are a serious CBD oil distributor that is changing the marketplace.

Lewis talks about his background, starting with the building of the very first bulk and wholesale B2B distribution platform for American-grown hemp and cannabinoids derived from hemp. He discusses some of the challenges, and some of the advances that were enabled after the passing of the US Farm Bill.

Lewis explains that hemp is excellent with phytoremediation, a form of bioremediation that applies to all the chemical or physical processes that involve plants for immobilizing or degrading contaminants within the soil and/or groundwater. He recounts some remarkable stories of how hemp has shown it can literally absorb all kinds of contaminants and survive, which makes testing incredibly important. Lewis explains their testing processes in detail. And he provides details about upcoming federal regulation and the marketplace, as well as his expectation for the near future in regard to the hemp-derived phytocannabinoids market.